Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$534M |
| 2 |
Amazon
AMZN
|
+$399M |
| 3 |
Abbott
ABT
|
+$381M |
| 4 |
Adobe
ADBE
|
+$353M |
| 5 |
Oracle
ORCL
|
+$261M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sherwin-Williams
SHW
|
+$407M |
| 2 |
Bank of America
BAC
|
+$368M |
| 3 |
TE Connectivity
TEL
|
+$366M |
| 4 |
Goldman Sachs
GS
|
+$302M |
| 5 |
Atlassian
TEAM
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.57% |
| 2 | Healthcare | 19.51% |
| 3 | Consumer Discretionary | 9.79% |
| 4 | Industrials | 9.79% |
| 5 | Financials | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SRC
776
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
| $5.85M | ﹤0.01% |
133,798
-1,791,365
| -93% | -$69.1M |
|
777
Omega Healthcare
OHI
$15B
| $5.84M | ﹤0.01% |
190,507
-112,874
| -37% | -$3.62M |
|
778
Indivior Pharmaceuticals
INDV
$4.75B
| $5.82M | ﹤0.01% |
385,371
| – | – |
|
779
CrowdStrike
CRWD
$189B
| $5.81M | ﹤0.01% |
91,076
-644
| -0.7% | -$33.7K |
|
|
BNY
780
Bank of New York Mellon
BNY
$106B
| $5.81M | ﹤0.01% |
111,632
-42
| -0% | -$1.93K |
|
781
W.W. Grainger
GWW
$64B
| $5.77M | ﹤0.01% |
6,958
-196
| -3% | -$151K |
|
782
LyondellBasell Industries
LYB
$19.5B
| $5.71M | ﹤0.01% |
60,054
+23,443
| +64% | +$2.19M |
|
783
Enliven Therapeutics
ELVN
$3.85B
| $5.68M | ﹤0.01% |
408,514
+132,098
| +48% | +$1.62M |
|
784
STAAR Surgical
STAA
$1.21B
| $5.67M | ﹤0.01% |
181,816
-14,434
| -7% | -$519K |
|
785
Old Dominion Freight Line
ODFL
$44.2B
| $5.57M | ﹤0.01% |
27,514
+648
| +2% | +$129K |
|
786
Prudential Financial
PRU
$42.6B
| $5.56M | ﹤0.01% |
53,628
-51,750
| -49% | -$4.96M |
|
787
Kinsale Capital Group
KNSL
$8.11B
| $5.52M | ﹤0.01% |
16,491
+2,040
| +14% | +$757K |
|
|
HOLX
788
DELISTED
Hologic
HOLX
| $5.5M | ﹤0.01% |
76,975
-30,166
| -28% | -$2.1M |
|
789
Nutanix
NTNX
$16B
| $5.5M | ﹤0.01% |
115,305
-3,844
| -3% | -$156K |
|
790
Realty Income
O
$60.1B
| $5.5M | ﹤0.01% |
95,677
-37,853
| -28% | -$1.99M |
|
791
Kinross Gold
KGC
$28.2B
| $5.49M | ﹤0.01% |
902,470
+801,339
| +792% | +$4.38M |
|
792
Charter Communications
CHTR
$16.9B
| $5.49M | ﹤0.01% |
14,114
+415
| +3% | +$169K |
|
793
MetLife
MET
$62.5B
| $5.48M | ﹤0.01% |
82,879
+3,340
| +4% | +$209K |
|
794
Biogen
BIIB
$30.7B
| $5.48M | ﹤0.01% |
21,174
+86
| +0.4% | +$21.1K |
|
795
FTI Consulting
FCN
$4.95B
| $5.47M | ﹤0.01% |
27,438
+11,652
| +74% | +$2.41M |
|
|
SF
796
Stifel
SF
$12.5B
| $5.46M | ﹤0.01% |
118,413
+41,298
| +54% | +$1.7M |
|
797
Applied Industrial Technologies
AIT
$12.6B
| $5.45M | ﹤0.01% |
31,588
+11,610
| +58% | +$1.88M |
|
798
Dominion Energy
D
$61.3B
| $5.45M | ﹤0.01% |
116,001
-655
| -0.6% | -$29.2K |
|
|
SSPX
799
DELISTED
Janus Henderson US Sustainable EquityETF
SSPX
| $5.44M | ﹤0.01% |
230,829
-50,084
| -18% | -$1.1M |
|
800
Ameriprise Financial
AMP
$48.1B
| $5.44M | ﹤0.01% |
14,323
-7,978
| -36% | -$2.74M |
|
Similar funds
Janus Henderson Group's Q4 2023 Portfolio in Review
As of Q4 2023, Janus Henderson Group held 2,657 positions worth $168B, up 9.8% from $153B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Janus Henderson Group's Q4 2023 filing shows 98 new, 642 increased, 1,760 reduced and 111 closed positions. Its largest new stake was Veralto: 2,881,576 shares worth $237M. The largest sale was Sherwin-Williams, an estimated $407M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q4 2023 buy was Veralto: 2,881,576 shares worth $237M.
- Janus Henderson Group added most to Eli Lilly in Q4 2023, an estimated $534M increase.
- Janus Henderson Group's biggest Q4 2023 reduction was Sherwin-Williams, cutting an estimated $407M.
- Janus Henderson Group fully exited National Instruments Corp in Q4 2023, selling an estimated $243M.
- Janus Henderson Group's ten largest holdings make up 27% of its $168B portfolio in Q4 2023.
- Janus Henderson Group opened 98 new positions and closed 111 in Q4 2023.
- Janus Henderson Group's portfolio value rose 9.8% quarter-over-quarter to $168B.
Based on Janus Henderson Group's 13F filing for Q4 2023, filed 14 Feb 2024.